Indian equity benchmarks advanced on Thursday, driven by gains in heavyweight financials, although a decline in Tata Motors ...

In an expert call, the brokerage addressed possibilities of pass-through of tariffs to consumers, and the feasibility of ...

Indian pharma stocks fell for the third consecutive session amid concerns of potential US tariffs on pharmaceutical imports.

Spooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...

Indian pharma companies may stand to gain market share due to the potential impact of US tariffs, according to a JPMorgan ...

Warns that Indian pharmaceutical products could become more expensive in the US, reducing their competitiveness in one of the ...

The e-commerce sector stands out as an exception, maintaining its competitive pay. Following e-commerce, there are other sectors, including automotive, pharmaceuticals, manufacturing, and financial ...

Satyanarayana Chava of Laurus Labs stated that global pharma firms prioritise sustainability, scale, and compliance over cost ...

Hetero Group founder, B Parthasaradhi Reddy, warns of potential US reciprocal tariffs on Indian pharmaceuticals, which could disrupt India's pharma industry, leading to higher prices and reduced ...

The session highlighted existing policy support mechanisms and upcoming opportunities under the PRIP scheme aimed at ...